[go: up one dir, main page]

LT2964199T - Sausos farmacinės kompozicijos, apimančios aktyvaus agento nanodaleles, prisirišusias prie nešiklio dalelių - Google Patents

Sausos farmacinės kompozicijos, apimančios aktyvaus agento nanodaleles, prisirišusias prie nešiklio dalelių

Info

Publication number
LT2964199T
LT2964199T LTEP14710757.7T LT14710757T LT2964199T LT 2964199 T LT2964199 T LT 2964199T LT 14710757 T LT14710757 T LT 14710757T LT 2964199 T LT2964199 T LT 2964199T
Authority
LT
Lithuania
Prior art keywords
nanodels
binded
particulars
carrier
pharmaceutical compositions
Prior art date
Application number
LTEP14710757.7T
Other languages
English (en)
Inventor
Maynard Emanuel Lichty
Garry T. Gwozdz
Original Assignee
Besins Healthcare Luxembourg Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Healthcare Luxembourg Sarl filed Critical Besins Healthcare Luxembourg Sarl
Publication of LT2964199T publication Critical patent/LT2964199T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTEP14710757.7T 2013-03-04 2014-03-03 Sausos farmacinės kompozicijos, apimančios aktyvaus agento nanodaleles, prisirišusias prie nešiklio dalelių LT2964199T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361772095P 2013-03-04 2013-03-04
PCT/US2014/019833 WO2014137877A1 (en) 2013-03-04 2014-03-03 Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles

Publications (1)

Publication Number Publication Date
LT2964199T true LT2964199T (lt) 2020-08-10

Family

ID=47901822

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14710757.7T LT2964199T (lt) 2013-03-04 2014-03-03 Sausos farmacinės kompozicijos, apimančios aktyvaus agento nanodaleles, prisirišusias prie nešiklio dalelių

Country Status (23)

Country Link
US (2) US10695295B2 (lt)
EP (1) EP2964199B1 (lt)
JP (1) JP6564708B2 (lt)
CN (1) CN105307639B (lt)
AU (1) AU2014226192B2 (lt)
BR (1) BR112015021525B1 (lt)
CA (1) CA2901015A1 (lt)
CY (1) CY1124635T1 (lt)
DK (1) DK2964199T3 (lt)
ES (1) ES2804702T3 (lt)
HR (1) HRP20201103T1 (lt)
HU (1) HUE050050T2 (lt)
IL (1) IL240867B (lt)
LT (1) LT2964199T (lt)
MX (1) MX375187B (lt)
PL (1) PL2964199T3 (lt)
PT (1) PT2964199T (lt)
RS (1) RS60481B1 (lt)
RU (1) RU2715714C2 (lt)
SI (1) SI2964199T1 (lt)
SM (1) SMT202000349T1 (lt)
WO (1) WO2014137877A1 (lt)
ZA (1) ZA201505852B (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10695295B2 (en) 2013-03-04 2020-06-30 Besins Healthcare Luxembourg Sarl Spray-dried pharmaceutical compositions comprising active agent nanoparticles
AU2017307306B2 (en) 2016-08-05 2022-06-30 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical powder compositions
US20200179277A1 (en) * 2017-05-19 2020-06-11 Milton S. Jackson Appetite suppressant
JP7453770B2 (ja) * 2019-10-25 2024-03-21 松本油脂製薬株式会社 複合粒子及びその製造方法
EP4358748A1 (en) * 2021-06-25 2024-05-01 Nicoventures Trading Limited Oral products and method of manufacture

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
FR2575678B1 (fr) 1985-01-04 1988-06-03 Saint Gobain Vitrage Ejecteur pneumatique de poudre
DK546289D0 (da) * 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
CN1155368C (zh) * 1996-02-27 2004-06-30 帝人株式会社 鼻腔给药的粉剂组合物
US6835389B1 (en) 1998-08-26 2004-12-28 Teijin Limited Powder Composition for nasal administration
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
PT1175214E (pt) 1999-12-08 2005-04-29 Pharmacia Corp Composicoes de inibidor de ciclo-oxigenase-2 com um inicio rapido do seu efito terapeutico
CA2433583A1 (en) 2001-07-05 2003-01-16 Translational Research Ltd. Composition of insulin for nasal administration
CN1176649C (zh) 2002-10-16 2004-11-24 上海医药工业研究院 舒马普坦干粉吸入剂及其制备方法
CN100581586C (zh) 2003-01-31 2010-01-20 奥雷克索公司 一种快速起效的药物组合物
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
US8673360B2 (en) 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
US7947308B2 (en) * 2005-07-20 2011-05-24 Raimar Loebenberg Effervescent powders for inhalation
US20070178166A1 (en) * 2005-12-15 2007-08-02 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
KR20080105174A (ko) * 2006-04-03 2008-12-03 테바 파마슈티컬 인더스트리즈 리미티드 약물 미립자
GB0625322D0 (en) * 2006-12-19 2007-01-24 Pharmakodex Ltd Pharmaceutical compositions
WO2008078730A1 (ja) 2006-12-26 2008-07-03 Translational Research, Ltd. 経鼻投与用製剤
GB0716907D0 (en) 2007-08-31 2007-10-10 Archimedes Dev Ltd Pharmaceutical powder compositions
US20110250274A1 (en) * 2008-09-19 2011-10-13 Shaked Ze Ev Estriol formulations
EP2429495A4 (en) * 2009-05-15 2014-01-22 Shin Nippon Biomedical Lab Ltd INTRANASAL PHARMACEUTICAL COMPOSITION WITH IMPROVED PHARMACOKINETICS
PL3111926T3 (pl) * 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego
US20110262502A1 (en) 2010-02-08 2011-10-27 Prairie Pharmaceuticals LLC Pulmonary delivery of 17-hydroxyprogesterone caproate (17-hpc)
CA2796646A1 (en) * 2010-04-22 2011-10-27 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions and administrations thereof
WO2012051426A2 (en) 2010-10-15 2012-04-19 Glaxo Group Limited Aggregate nanoparticulate medicament formulations, manufacture and use thereof
EP2540281A1 (en) * 2011-06-30 2013-01-02 LEK Pharmaceuticals d.d. Solid self-microemulsifying systems
US10695295B2 (en) 2013-03-04 2020-06-30 Besins Healthcare Luxembourg Sarl Spray-dried pharmaceutical compositions comprising active agent nanoparticles

Also Published As

Publication number Publication date
MX2015011624A (es) 2015-12-17
IL240867B (en) 2020-11-30
US20140248367A1 (en) 2014-09-04
IL240867A0 (en) 2015-10-29
PL2964199T3 (pl) 2021-01-25
BR112015021525A2 (pt) 2017-07-18
US10918601B2 (en) 2021-02-16
WO2014137877A1 (en) 2014-09-12
EP2964199B1 (en) 2020-04-22
MX375187B (es) 2025-03-06
HUE050050T2 (hu) 2020-11-30
CN105307639B (zh) 2020-06-30
HRP20201103T1 (hr) 2021-02-05
RU2715714C2 (ru) 2020-03-03
AU2014226192A8 (en) 2016-04-21
ZA201505852B (en) 2017-07-26
AU2014226192A1 (en) 2015-09-03
RS60481B1 (sr) 2020-08-31
JP2016510742A (ja) 2016-04-11
US20200390706A1 (en) 2020-12-17
CY1124635T1 (el) 2022-03-24
SMT202000349T1 (it) 2020-09-10
CA2901015A1 (en) 2014-09-12
DK2964199T3 (da) 2020-06-15
JP6564708B2 (ja) 2019-08-21
RU2015141792A3 (lt) 2018-03-01
US10695295B2 (en) 2020-06-30
CN105307639A (zh) 2016-02-03
RU2015141792A (ru) 2017-04-07
AU2014226192B2 (en) 2018-07-26
BR112015021525B1 (pt) 2022-06-14
PT2964199T (pt) 2020-05-12
ES2804702T3 (es) 2021-02-09
SI2964199T1 (sl) 2020-10-30
EP2964199A1 (en) 2016-01-13

Similar Documents

Publication Publication Date Title
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
PL3061454T3 (pl) Pasożytobójcze doustne kompozycje weterynaryjne obejmujące systemowo działające środki aktywne, sposoby i ich zastosowania
SI2958913T1 (sl) Sfingozin-1-fosfat receptor agonisti, postopki za njegovo pripravo in farmacevtski sestavki, ki ga vsebujejo kot aktivno sredstvo
JP2015512729A5 (lt)
BR112015002738A2 (pt) composto , e , composição farmacêutica
DK4374878T3 (da) Farmaceutisk sammensætning, der omfatter carbetocin
HUE063336T2 (hu) Adagolási rend echinokandin osztályba tartozó vegyületekhez
DK2900645T3 (da) Herbicidt aktive 3-phenylisoxazolinderivater
DK3043778T3 (da) Farmaceutiske sammensætninger, der indeholder refametinib
PT2935269T (pt) Derivados de pirazolo-pirimidina terapeuticamente activos
LT3003268T (lt) Stabilūs peroraliniai tirpalai, skirti kompleksiniam aktyviam farmaciniam ingredientui (api)
SMT201500320B (it) Liofilizzazione di agente tensioattivo polmonare liposomale sintetico
FR3013218B1 (fr) Composition comprenant des capsules gelifiees stabilisees par un tampon
ZA201505318B (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
CL2014003283A1 (es) Formulación farmacéutica.
PL2836580T3 (pl) Mikrofibrylarna celuloza jako substancja czynna zdolna do odrywania brudu
BR112015010597A2 (pt) secagem mediante mistura de polissacarídeo nanofibrilado".
SMT201500235B (it) Formulazione comprendente derivato di fenilamminopirimidina come agente attivo
LT2964199T (lt) Sausos farmacinės kompozicijos, apimančios aktyvaus agento nanodaleles, prisirišusias prie nešiklio dalelių
DK2919761T3 (da) Fast doseringsform omfattende mikroniseret cytisin
EP2968195A4 (en) PHARMACEUTICAL FORMULATION WITH GLYCOSAMINOGLYCAN
HUE036048T2 (hu) Gyógyszerészetileg aktív vegyületek
EP2988734C0 (en) FORMULATION OF A HARD CAPSULE
PT2980085T (pt) Compostos farmaceuticamente activos
DE112013005825A5 (de) Reduktionsmittelzuführeinrichtung